Harvard Bioscience, Inc.
USD5.98
-0.15 (-2.38%)
CEO
John D. Duke
IPO Date
2001-03-19
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ
Country
US
Open
$6.04
Prev. Close
$6.13
Day Low
$5.86
Day High
$6.10
52W Low
$3.80
52W High
$9.40
Market Cap
$0.03B
Volume
0.01M
| 16,556 |
| $0.00 |
| 11 Jun 2026 | DENELSKY STEPHEN J | director | A-Award | Acquired | 16,556 | $0.00 |
| 11 Jun 2026 | Gagnon Robert E. | director | A-Award | Acquired | 16,556 | $0.00 |
| 11 Jun 2026 | Benson Seth Benjamin | director | A-Award | Acquired | 16,556 | $0.00 |
| 1 Apr 2026 | Frost Mark T | Chief Financial Officer | A-Award | Acquired | 30,000 | $0.00 |
| 1 Apr 2026 | Frost Mark T | Chief Financial Officer | P-Purchase | Acquired | 5,000 | $5.00 |
| 23 Mar 2026 | Duke John D | director, officer: Chief Executive Officer | A-Award | Acquired | 75,000 | $0.00 |
| 18 Mar 2026 | Snider William | director | P-Purchase | Acquired | 12,525 | $4.99 |
| 18 Mar 2026 | Snider William | director | P-Purchase | Acquired | 8,475 | $4.85 |